word/phrase,value,class
keep,0.000652806186983721
sachin,0.004848662109459305
bindal,0.005479752247119642
amit,0.004479498044353054
koli*,0.0013699380617799104
ever,0.00021332072633344838
since,9.427483527074658e-05
india,0.004724878908576233
opened,0.0003063197296597796
patent,0.023058555775943436
regime,0.0006512489820871705
january,0.0001506844659053028
include,0.00017518034888622098
product,0.001721491110538508
ﬁeld,0.0025109854680987606
pharmaceutical,0.008633615725088804
law,0.00017804008720841613
domain,0.0020138486939448703
kept,0.0003000257529967736
alive,0.000498471692974054
interest,0.0001809412613483708
various,0.00033973875545446333
stakeholder,0.002168435647214426
rightly,0.0006197474097049695
also,3.5793608951613175e-05
known,0.0003237931532847764
pharmacy,0.0008043294422580945
world,0.00012886728937101642
global,0.00015502017133821154
market,0.00025239541168086717
leader,0.0003482451861798514
export,0.000500127101383294
generic,0.0020475181057909666
drug,0.009604667578554478
united,0.0001556173694210177
state,0.00010129448885851194
japan,0.00031061452977260536
well,0.00011041139954764577
country,0.0001215147473341809
africa,0.00032400766628853207
europe,0.00028866386611264605
indian,0.003975465353226447
industry,0.00012244789316795762
turnover,0.0008966204585346571
billion,0.0009073939149579337
registering,0.0006034820880383192
growth,0.0002602570892139963
rate,0.0003286530857493838
per,0.00018666836845224565
cent,0.000595765496413211
stood,0.0006283377745834649
r,0.0012121655273648261
crore,0.0013699380617799104
one,2.242651835615702e-05
largest,0.00030210446747140754
consumer,0.00023558121912559333
medicine,0.001199030618171374
even,9.22500312054426e-05
though,0.00030226084120477695
accessibility,0.0006114694918940513
across,0.00033942055609386914
economically,0.00041629868256509456
weaker,0.0006769510100325733
section,0.0001829236143037805
remains,0.00019807147300314698
issue,0.0001418122844019167
equipped,0.0006372651012599746
balance,0.00021473890944452012
quid-pro-quo,0.0013699380617799104
requirement,0.0010681697902704705
jurisprudence,0.00046197487528988504
still,9.717372974007646e-05
evolving,0.00044966822128070114
recent,0.0001433129634763174
judicial,0.0003000257529967736
precedent,0.00038418670314217915
reafﬁrmed,0.0008966204585346571
ofﬁce,0.0021205112240800334
proposed,0.0009146331207194254
disclosure,0.0036938436326205844
international,0.00017715289298871474
nonproprietary,0.002886305930019537
name,0.0033196344602954295
application,0.002412074710084659
relating,0.0005648837488280053
pharmainventions,0.0013699380617799104
thereafter,0.0005138225190233137
organized,0.00032631852525344564
ceutical,0.0013699380617799104
meeting,0.0005830248006128534
different,0.0001077589707708257
discus,0.00022641416872709466
proposal,0.002063593992851227
receive,0.00024351295032530883
feedback,0.0006034820880383192
feasibility,0.0007535380308282956
implementation,0.00020093967531330988
policy,6.492837654676866e-05
make,6.662150726281026e-05
mandatory,0.0017519718479925062
rule,0.00025964701567765617
amended,0.0006212290595452107
provide,0.00023269657976735832
necessary,7.858953505773686e-05
basis,7.70305039423269e-05
put,0.00010161743888171453
voiced,0.0006114694918940513
concern,0.0002715764832899021
ﬁnally,0.0010069489602732972
decided,0.0002190472586304169
reject,0.0008537749186818527
least,7.317901352191506e-05
making,0.00013578824164495106
remain,0.0001391703138511051
unchanged,0.0005810753897044881
go,9.648298840338637e-05
credit,0.0004840910596685302
speciﬁcation,0.0027989270878893925
removed,0.000217602062327907
recently,0.00026032896958613154
issued,0.0005034621734862176
guideline,0.0009361100359075328
examination,0.0006974529976118111
however,2.504425634209793e-05
instruct,0.000712038425981532
examiner,0.004460855708819823
search,0.010981157845868813
prior,0.001453487339854947
art,0.0005793317968622203
based,0.00013197257987856013
disclosed,0.0010276450380466275
case,6.464073853966035e-05
second,9.854698962300887e-05
medical,0.0013026918032473303
use,0.00012519042185015844
invention,0.002265579780687979
author,0.00024220391632383373
koli,0.004109814185339731
associate,0.00035604998460822925
partner,0.0012868801297192226
gurgaon,0.002739876123559821
attempt,0.0002155155729184692
explore,0.0006084046817496011
tool,0.001506488659030548
searching,0.0023974628342244507
whether,0.00013336156985529376
would,0.00011538113239305072
indeed,0.000237371064504549
thing,0.00029075690568924493
simpler,0.0014500973799767246
directed,0.0003000257529967736
ask,0.00030845700032038726
applicant,0.004397099241712653
disclose,0.0018147878299158674
substance,0.0029574708721065808
claimed,0.0004154694734404223
event,0.00025254697998528577
give,0.00015874614672653367
information,0.00017518034888622098
upon,0.00015096415712568788
request,0.0004498431772101366
required,0.00019636327097640878
seek,0.00013713799987668068
ascertain,0.0005302839782746891
examine,0.00047116243825118666
discussed,0.0001381518886487979
held,7.70305039423269e-05
dropped,0.0012745302025199492
general,7.313813157840001e-05
background,0.00020228255621718852
ofﬁcial,0.0011707706008570644
given,6.284989018049772e-05
designated,0.0007282638674004145
health,0.0031230850705679554
organization,0.00041445566594639367
identiﬁes,0.0006114694918940513
active,0.0008820067579069341
ingredient,0.002055290076093255
unique,0.0003708285470555497
globally,0.0005034744801366486
recognized,0.0003633858422149428
email,0.00024676468638468245
thank,0.00032631852525344564
dr,0.0002959244230638824
deepa,0.0013699380617799104
kachroo,0.0013699380617799104
tiku,0.0013699380617799104
providing,0.0001321352127140861
unconditional,0.000824134767671826
guidance,0.0005798154942583412
critical,0.00017088055133429936
comment,0.00046178543359279116
without,2.5773457874203283e-05
paper,9.22910162765625e-05
could,4.051779554340477e-05
written,0.00019827745019314477
fullest,0.0008043294422580945
view,0.0001215147473341809
expressed,0.00017323930459775658
solely,0.00027092862100000666
alone,0.00020773473672021115
way,1.6655376815702565e-05
represent,0.00017803143218678686
aiswariya,0.0013699380617799104
chidambaram,0.0013699380617799104
insight,0.00031061452977260536
snapshot,0.0007388479241195725
july,0.00024111787829731438
available,0.0007179543349538703
frostcomsublibdisplay-market-insight-topdoid=,0.0013699380617799104
may,9.174184670114404e-05
business,0.0001186855322522745
ministry,0.000274599953059052
external,0.00030845700032038726
affair,0.0002451330116340834
government,0.00011965905582564506
investment,0.00020911843492053004
technology,0.0004175109415533153
promotion,0.0002840460244077273
division,0.00025341092944500157
industryserviceslanding,0.0013699380617799104
june,0.0003788204699779287
controller,0.0008698109603966164
design,0.0001685459908383612
trade,0.0002548040665908475
mark,0.00016971027804693457
field,0.0005487798724316552
october,0.00028244187441400266
para,0.0006764768064173313
new,3.846037746435024e-05
therapeutic,0.0012566755491669299
us,0.00016281224552179262
published,0.0006518919542204845
oxford,0.0001253110460513445
university,4.051779554340477e-05
press,4.249865979222824e-05
right,0.00012062750756558053
reserved,0.00031061452977260536
table,0.003954630431372407
understanding,9.903573650157349e-05
indication,0.00029189568686561665
n-hydroxyphenylethanamide,0.0013699380617799104
paracetamol,0.0012121655273648261
anti-pyretic,0.0013699380617799104
-acetoxybenzoic,0.0013699380617799104
acid,0.0024129883267742834
aspirin,0.00802881265215954
analgesic,0.0011198745110882636
antipyretic,0.0013699380617799104
anti-inﬂammatory,0.0012121655273648261
easy,0.00025680827091665795
remember,0.00046622953473547175
unlike,0.0002899077471291706
union,0.00019695792387173678
pure,0.0004577982874118581
applied,0.00020845751981682516
chemistry,0.0013994635439446962
nomenclature,0.00412067383835913
apart,0.00030420234087480055
system,0.00015403770151633663
british,0.00018792941130647963
approved,0.0019032756292897848
adopted,0.0002702473424349544
identify,0.00034647860919551315
provides,0.00017634970503403738
example,3.810274846838976e-05
question,6.540023469936485e-05
using,0.00026208143165699677
raised,0.00019304463001148817
number,0.00010581628678921102
including,0.00010387911397523057
following,0.00014782048443451331
suddenly,0.0006114694918940513
sought-after,0.0010543929929497417
beneﬁcial,0.0005480294013674393
regarding,0.00014329020284903086
might,6.272915506164907e-05
extra,0.0005085896988416571
burden,0.0009253710009611618
seeking,0.00039391584774347356
vested,0.000524663503750699
group,4.183213617396968e-05
agency,0.0003584907917605557
fueling,0.0013699380617799104
sudden,0.0019990866997702246
need,4.907280473481009e-05
related,0.0003968653668163342
method,0.0010698939675026465
synthesis,0.0038793414470580595
string,0.01847119810298931
type,0.00033132279984316235
jurisdiction,0.000652806186983721
result,0.0005302285592310463
title,0.0021343104700051615
acetoxybenzoic,0.0013699380617799104
cooperation,0.0002655303208743191
treaty,0.0002063593992851227
composition,0.0030976124045466215
rotigotine,0.017809194803138834
rotigotina,0.0013699380617799104
thiophen,0.0013699380617799104
tetrahydronaphthalen,0.0013699380617799104
thienyl,0.0013699380617799104
tetrahydro,0.0013699380617799104
naphthalenol,0.0013699380617799104
claim,0.0006286867765625496
exclamation,0.0013699380617799104
wildcard,0.0013699380617799104
represents,0.00023095154793699953
zero,0.0006114694918940513
unlimited,0.0005480294013674393
character,0.00020499232218474105
earlier,0.00013312701233552477
premise,0.00038418670314217915
help,0.00013713799987668068
conduct,0.00023872082273627856
effectively,0.00021191132459823808
hypothesis,0.0006465569078430099
designed,0.0005948323505794343
sample,0.0007565484477836361
shown,0.0007024910291891827
found,0.0004274987878289092
used,0.000180414205119423
two,7.380002496435408e-05
relevant,0.0012194092665805743
four,0.0004860058266272553
document,0.001039830366712866
fact,7.183931384721714e-05
appeared,0.0005758740384163005
missed,0.004198390631834089
common,6.345987046605433e-05
thus,0.00011558545139181676
prove,0.000274599953059052
effective,0.00027427599975336135
instance,0.00012435265451758766
conﬁrm,0.0007535380308282956
provisional,0.0006034820880383192
conclusion,0.0004449607598479897
another,3.2061638241025145e-05
study,0.0002395114999207268
treatment,0.0004468774644021029
parkinson,0.0024243310547296523
disease,0.0013371286608697042
restless,0.0011198745110882636
leg,0.0008043294422580945
syndrome,0.0009270145607242204
trial,0.0006964903723597028
changed,0.00019304463001148817
subject,0.0001437068999524361
matter,0.0001342981083799677
molecule,0.0007692420263091358
broaden,0.0006997317719723481
presumption,0.0005138225190233137
old,0.00015502017133821154
nevertheless,0.00019175500813116487
miss,0.000595765496413211
generally,0.00010161743888171453
reached,0.00025680827091665795
mentioned,0.0005161706177174456
captured,0.002823391441010283
three,0.00011678689925748064
belong,0.0003482451861798514
family,0.000217602062327907
discloses,0.0008966204585346571
comprising,0.00045369695747896684
addition,0.00016986937772723166
salt,0.0023077260789274075
remaining,0.0002899077471291706
talk,0.00036140594120240434
novel,0.0003696838590133226
word,0.0002572212477306731
whointmedicinesservicesinninnquidanceen,0.0013699380617799104
april,0.0007216596652816152
ﬁnds,0.0005480294013674393
term,6.412327648205029e-05
appear,0.0005056379725150836
within,1.905137423419488e-05
n-number,0.0013699380617799104
conducted,0.0004902660232681669
total,0.0009485824311134053
database,0.001277820645898169
december,0.0002763037772975958
wn,0.0013699380617799104
operator,0.0005191784756174888
polymorph,0.0024243310547296523
axitinib,0.006849690308899552
pyridin,0.004109814185339731
indazol,0.0013699380617799104
sulfanyl,0.0013699380617799104
highly,0.0004456415857340855
already,0.00016031863639362826
among,0.0002126970539028708
listed,0.00027275688507014367
orange,0.007417212909046433
book,0.0010103235313942613
book-listed,0.002739876123559821
food,0.0011918634027031692
administration,0.0009548832909451143
approval,0.0028750964532708798
fail,0.00035604998460822925
efﬁcient,0.0005302839782746891
obtain,0.00039655490038628953
crystalline,0.002239749022176527
form,8.857644649435737e-05
disclosing,0.0036942396205978624
corresponding,0.001199030618171374
currently,0.00014537845284462247
molecular,0.0007388479241195725
formula,0.000498471692974054
structural,0.00042688745934092633
diagram,0.0007861103089985495
clinical,0.0006880565126897736
code,0.00022791660093443385
systematic,0.00042330285528940356
chemical,0.0017986728851228046
abstract,0.0010036015815199425
service,0.00010687038707797415
registry,0.0005480294013674393
etc,0.00022641416872709466
tried,0.0003902568669523548
tested,0.0010276450380466275
well-established,0.0006562442273891385
worldwide,0.0003668909693356145
ing,0.0006465569078430099
data,0.00019827745019314477
major,9.989305447550386e-05
requires,0.0004361353585338674
sometimes,0.00018046586879358117
conﬂict,0.00040290554604916786
referred,0.00018541427352777485
national,5.905096432957158e-05
de´nominations,0.0013699380617799104
commune,0.0009270145607242204
francaises,0.0013699380617799104
japanese,0.00039335375354067787
similar,0.0001730363817907045
purpose,0.00010827758036630722
difference,0.00013016448479306577
flurothyl,0.0013699380617799104
whereas,0.00023872082273627856
flurotyl,0.0013699380617799104
lead,0.00011044093328105412
confusion,0.0008058110920983357
concluded,0.00021473890944452012
create,0.0001059864339165823
prosecution,0.0004749851392967153
link,0.0007121257287471475
good,5.982952791282253e-05
idea,0.00011134239051075738
take,6.158005586766255e-05
linking,0.0008836371176456237
unnecessarily,0.0007388479241195725
cumbersome,0.0006769510100325733
ﬁling,0.0015908519348240674
best,0.00033402717153227214
responsibility,0.00020773473672021115
regulatory,0.002220488234171416
body,0.0001140683830085602
stage,0.0010681885931207212
time,2.154691284655345e-05
ﬁled,0.0008836371176456237
soon,0.00025852614815001013
research,8.499731958445649e-05
development,3.7220332765665276e-05
show,8.493468886361583e-05
promise,0.00037827422389181807
accordingly,0.0002802204275830421
compound,0.0011213561609285047
unlikely,0.000274599953059052
patenting,0.0019551374937117018
actually,0.00016394749801472119
laboratory,0.00047949256684489013
acronym,0.0007861103089985495
naming,0.0006465569078430099
therefore,5.625617896813267e-05
practical,0.0003536478172985587
challenge,0.0001253110460513445
almost,0.00013114771592448893
never,0.00012918548262581247
besides,0.0004418185588228118
allow,0.00012918548262581247
adding,0.00041629868256509456
inclusion,0.0005455137701402873
present,7.968839287504726e-05
viable,0.0004095036211581933
approach,5.767879393023483e-05
internationally,0.00030420234087480055
done,0.00015284199535752093
applying,0.00027092862100000666
linkage,0.0026514198913734455
meant,0.00021051059615938752
prevent,0.00015502017133821154
infringement,0.0005310606417486383
followed,0.0001829266241438851
several,0.00013281283689610347
member,0.00013281283689610347
closer,0.0003753745967429915
collaboration,0.00034570194572156407
regulator,0.000712038425981532
website,0.00032172003242980564
repository,0.0005419592375572636
exercise,0.00022050168947673353
kyoto,0.000824134767671826
bioinformatics,0.0010036015815199425
center,0.00026911492492584185
obtained,0.0002249215886050683
presented,0.00024111787829731438
performed,0.0006764768064173313
acting,0.00032400766628853207
dopamine,0.0013699380617799104
agonist,0.0013699380617799104
indicated,0.0002979658506757923
expiry,0.0013994635439446962
november,0.0002783406277022102
march,0.0005050939599705715
september,0.0002845064371633784
submitted,0.00026911492492584185
sponsorapplicant,0.0013699380617799104
depending,0.00033339529171238017
status,0.0005325080493420991
publishes,0.0006997317719723481
list,0.00026032896958613154
mapped,0.000824134767671826
year,3.270011734968242e-05
back,0.00012339828140876913
decree,0.00047949256684489013
gazette,0.002136115277944596
federal,0.0002517310867431088
mexico,0.0004577982874118581
regulation,0.00026032896958613154
industrial,0.0003809453035295338
property,0.00017804008720841613
amendment,0.000552916133334718
imposed,0.00024676468638468245
mexican,0.0013539020200651465
institute,0.00014122093720700133
obligation,0.00018792941130647963
publish,0.0004305294194852281
special,0.00010248455479891183
listing,0.00044966822128070114
allopathic,0.0013699380617799104
brought,0.00014433193305632303
beneﬁt,0.0003172126048816308
owner,0.0003759331381540335
authority,0.00040870001347504423
grant,0.00032111717396525816
registration,0.0006434400648596113
covering,0.00040290554604916786
marketing,0.001098399812236208
inform,0.00035604998460822925
holder,0.00047429121555670264
licensee,0.0004935765010169559
existing,0.0003477120575729614
licence,0.0003587122097283944
must,0.00010581628678921102
declaration,0.0002620012943234971
infringe,0.0014663531202837765
work,3.142494509024886e-05
determine,0.00014961332203214438
pending,0.00046197487528988504
indicates,0.00028598320761525557
valid,0.00032400766628853207
infringed,0.0004749851392967153
opportunity,0.00012150145665681383
demonstrate,0.00027275688507014367
alternative,0.00014537845284462247
similarly,0.00018046586879358117
china,0.0005918488461277648
maintains,0.0009155965748237162
separate,0.00019827745019314477
track,0.00043423060108244344
compoundcomposition,0.0013699380617799104
check,0.0009324590694709435
certify,0.000962101976673179
acknowledge,0.0003000257529967736
liability,0.0003996768727237913
damage,0.0002063593992851227
resulting,0.00020773473672021115
future,4.9273494811504434e-05
ﬁnding,0.0004305294194852281
frequent,0.00047949256684489013
inspection,0.000574071216980179
order,4.116755861284e-05
avoid,0.0001904726517647669
copying,0.0004418185588228118
patented,0.00041629868256509456
justiﬁed,0.000498471692974054
aim,0.0001321352127140861
professional,0.00042382264919647617
universally,0.0005191784756174888
existence,0.00015944007046654634
identiﬁcation,0.0005480294013674393
safe,0.0004095036211581933
prescription,0.0006372651012599746
dispensing,0.0010543929929497417
patient,0.0005480294013674393
communication,0.00017682390864927935
exchange,0.00020911843492053004
role,9.992440461025336e-05
mainly,0.00024351295032530883
commercial,0.0002318080383819743
reader,0.00031945516147454224
recall,0.00046197487528988504
bayer,0.002689861375603971
cipla,0.000962101976673179
high,0.0001618965766423882
court,0.00048223575659462877
supreme,0.0005310606417486383
clearly,0.00025964701567765617
ruled,0.00038418670314217915
overlap,0.0009775687468558509
apply,0.000250622092102689
context,5.204091677976055e-05
equivalence,0.0007535380308282956
evaluation,0.00035341853734667224
engine,0.0005810753897044881
docsqueryaicfm,0.0013699380617799104
report,0.0001540610078846538
joint,0.0002959244230638824
commission,0.00017924539588027786
commerce,0.0003508171644265727
device,0.0003406991585589696
subgroup,0.0009270145607242204
task,0.00023248433253727038
force,0.00010161743888171453
august,0.00035606286437357373
beijing,0.0006769510100325733
sa´nchez,0.0013699380617799104
reform,0.00031061452977260536
introduced,0.00020093967531330988
managing,0.00033101183901284106
intellectual,0.00024300291331362766
no,0.000595765496413211
delhi,0.0006197474097049695
judgement,0.0004935765010169559
pronounced,0.0006769510100325733
appeal,0.0001816929211074714
civil,0.00019175500813116487
disposed,0.0006465569078430099
finston,0.0012121655273648261
consulting,0.0005810753897044881
serial,0.0008698109603966164
almotriptan,0.002739876123559821
hit,0.008560572886516718
dimethylaminoethyl,0.0013699380617799104
indol,0.0013699380617799104
pyrrolidin,0.0013699380617799104
alvimopan,0.002739876123559821
ibrutinib,0.002739876123559821
hydroxyphenyl,0.0013699380617799104
dimethylpiperidin,0.0013699380617799104
methyl,0.0012121655273648261
phenylpropanoyl,0.0013699380617799104
phenoxyphenyl,0.0013699380617799104
pyrazolo,0.0013699380617799104
pyrimidin,0.0013699380617799104
piperidin,0.002739876123559821
bortezomib,0.002739876123559821
pyrazin,0.0013699380617799104
phenylalanin,0.0013699380617799104
leucin,0.0013699380617799104
boronic,0.0013699380617799104
crizotinib,0.002739876123559821
dichloro,0.0013699380617799104
ﬂuoro,0.0013699380617799104
pyrazol,0.0013699380617799104
prasugrel,0.002739876123559821
cyclopropyl,0.0013699380617799104
tetrahydrothieno,0.0013699380617799104
levomilnacipran,0.002739876123559821
diethyl,0.0013699380617799104
phenyl,0.0013699380617799104
cyclopropan,0.0013699380617799104
carboxamid,0.0013699380617799104
allocated,0.0005480294013674393
advice,0.0003668909693356145
expert,0.00038351001626232975
advisory,0.00042688745934092633
panel,0.0003286530857493838
pharmacopoeia,0.0010036015815199425
preparation,0.00038418670314217915
process,4.249865979222824e-05
selection,0.0003286530857493838
follows,0.00021051059615938752
main,0.00011134239051075738
step,0.00012435265451758766
requestapplication,0.0013699380617799104
made,1.6655376815702565e-05
company,0.0001321352127140861
review,8.333174102073322e-05
selected,0.0002821251889326721
time-period,0.0012121655273648261
objection,0.0003696838590133226
lapsed,0.0007535380308282956
recommended,0.00040618067669749157
importantly,0.00031061452977260536
speciﬁcally,0.0003508171644265727
human,0.0001077577864592346
substantial,0.0001829266241438851
regard,0.00010954303210489054
description,0.0005310606417486383
risk,0.00015284199535752093
losing,0.0004418185588228118
novelty,0.00043423060108244344
due,0.00022268478102151475
delay,0.0003996768727237913
obtaining,0.0006620236780256821
lack,8.333174102073322e-05
clarity,0.00045369695747896684
consequence,0.00014329020284903086
mandate,0.0003996768727237913
possible,8.499731958445649e-05
loss,0.00016508844102010618
decides,0.000574071216980179
withhold,0.0008043294422580945
want,0.00019175500813116487
misuse,0.0005085896988416571
third,9.312325725121235e-05
party,7.780868471050886e-05
frivolous,0.0008698109603966164
opposition,0.0002840460244077273
invalidation,0.0007861103089985495
proceeding,0.00021191132459823808
particularly,7.70305039423269e-05
ground,0.00010864865903674741
act,0.0001335300654063121
difﬁculties,0.00044570955362323474
specifying,0.0006372651012599746
component,0.00022641416872709466
markush,0.002739876123559821
representation,0.0004935293727693649
deﬁnes,0.000498471692974054
shall,0.0001685459908383612
contain,0.00024840814228240703
performing,0.000750749193485983
applicantinventor,0.0013699380617799104
entitled,0.00019564600293158778
protection,5.134590050544554e-05
reliable,0.0004935765010169559
source,7.937307336326684e-05
describing,0.00045369695747896684
aid,0.00035604998460822925
enabling,0.0003725114438596046
person,0.00010954303210489054
skilled,0.0005480294013674393
carry,0.00022942901615324317
wise,0.0006562442273891385
imposes,0.0004749851392967153
overcome,0.00038418670314217915
important,2.5154089728800602e-05
legal,0.0001417980359352472
barrier,0.0003000257529967736
legally,0.00025510326179835514
speaking,0.00034570194572156407
agreement,0.00019296597680677275
trade-related,0.0006997317719723481
aspect,5.484240018079996e-05
said,0.00013412315245053217
cannot,5.767879393023483e-05
discriminate,0.0007535380308282956
ﬁelds,0.000524663503750699
rejecting,0.0005883019539003126
saved,0.0005360467583069025
potentially,0.00024190433830870685
accused,0.0004749851392967153
discrimin,0.0013699380617799104
herein,0.0006663622332567416
symbol,0.00032400766628853207
indicate,0.00025510326179835514
collection,0.00015611712600584456
structure,0.0001253110460513445
commonly,0.0002959244230638824
text,0.00015832702349073108
ation,0.0010036015815199425
contrary,0.0002036334067873199
careful,0.00040618067669749157
thought,0.00019175500813116487
require,0.0001351236712174772
came,0.00015176067430732522
surprise,0.0005138225190233137
pharma,0.0008043294422580945
debate,0.0002783406277022102
longer,0.00013016448479306577
restricted,0.0002602570892139963
evokes,0.0007692420263091358
serious,0.000217602062327907
emotive,0.0007861103089985495
certainly,0.00021191132459823808
faced,0.00030845700032038726
dilemma,0.0004128757962134395
address,0.00012339828140876913
admirably,0.0011198745110882636
took,0.00015392847786426374
reasonable,0.00023095154793699953
balanced,0.0004418185588228118
pursuant,0.0004095036211581933
elaborate,0.0004840910596685302
discussion,7.937307336326684e-05
augur,0.0011198745110882636
fraternity,0.000962101976673179
thoroughly,0.0005542658915664475
usefulness,0.0006769510100325733
great,9.063560786732257e-05
impact,0.00011044093328105412
initiating,0.000712038425981532
nationwide,0.0008698109603966164
outlined,0.0003872015505683277
drawn,0.00024676468638468245
ie,0.0002161659840438248